Markets
$1.3B
J. Edward Moreno

Verve Therapeutics rose more than 75% in premarket trading after Eli Lilly announced that it would buy the gene-editing biotech company.

The acquisition is a sign Lilly is looking for other paths to sustain growth after the patents for its blockbuster weight-loss and diabetes drugs expire about a decade from now. Verve generated $32.3 million in revenue last year and has not yet reported a profitable quarter.

Verve’s experimental therapy “has the potential to be the first in vivo gene editing therapy for broad patient populations and could shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment,” Ruth Gimeno, Lilly’s vice president of diabetes and metabolic R&D, said in a statement.

Lilly said it would pay $10.50 per share in cash for Verve, with an additional $3 per share in the event that a phase three clinical trial for its lead program starts within a decade of closing. The stock closed at $6.27 on Monday and is above $10 before market open.

More Markets

See all Markets
markets
J. Edward Moreno

Molina implodes after earnings miss, gloomy guidance

Molina Healthcare tanked after it reported earnings results that missed Wall Street expectations and gave disappointing full-year guidance.

For the last three months of 2025, Molina reported:

  • An adjusted loss per share of $2.75, compared to the $0.34 earnings per share analysts polled by FactSet were expecting. The company said about $2 per share of its earnings miss was due to “retroactive premium adjustments attributable to the Company’s Medicaid business in California and ongoing medical cost pressure in Medicare and Marketplace.”

  • Revenue of $11.3 billion, compared to the $10.8 billion the Street was penciling in.

  • A medical cost ratio of 94.6%, higher than the 93.1% analysts expected.

For the full year in 2026, Molina expects:

  • Adjusted earnings per share of at least $5.00, compared to the $13.66 analysts had forecast. Molina said its guidance takes into account ongoing losses in its traditional Medicare Advantage Part D business, which it now plans to exit in 2027.

  • Revenues of about $42.2 billion, compared to the $46.6 billion analysts had penciled in.

  • Its medical cost ratio to sit at 92.6%, while analysts had expected 91.4%.

Health insurers have been under pressure for the past year amid rising health costs. Molina, one of the largest providers of ACA Marketplace plans, has taken a hit as tax credits for the program lapsed in January.

Molina’s report also dragged down competitors, including Centene, which is also a major provider of ACA plans and reports earnings Friday morning.

Read more
Bloom Energy Reports earnings

Bloom Energy surges after topping expectations for sales, EPS

Here’s how the print looked at first glance.

Matt Phillips2h
markets
Max Knoblauch

Roblox surges as it guides for stronger-than-expected full-year bookings, touts AI vision

Kid-centric gaming platform Roblox reported its fourth-quarter results after the market closed on Thursday. Its shares surged more than 20% in after-hours trading.

For the full year ahead, Roblox guided for bookings of between $8.28 billion and $8.55 billion, which would represent annual growth of 22% to 26%. That’s well ahead of Wall Street’s estimates: analysts polled by FactSet expected $8.03 billion.

Roblox forecasts Q1 bookings to land between $1.69 billion and $1.74 billion, compared to the $1.7 billion Wall Street consensus estimate.

An average of 144 million daily users logged on to Roblox in its fourth quarter, beating estimates of 138 million and up 69% from last year. The platform paid out $1.5 billion to creators last year, up from $922 million in 2024.

Roblox engagement surged in 2025, a year marred by several legal issues surrounding child safety on the platform. Late last year, analysts began to warn that some of its most popular titles were past their peak.

Recently, shares of the company have dropped on investor fears of Google’s Project Genie AI tool, which generates playable worlds. As of Thursday’s close, Roblox had shed more than $10 billion in market cap since Project Genie launched. On Wednesday, Roblox appeared to answer Genie’s release with the open beta launch of its own “4D” generative-AI tool. Roblox’s tool lets users generate objects made up of multiple working parts (e.g., a drivable car with spinning wheels) as opposed to static 3D objects.

In its letter to shareholders, Roblox said it was “innovating aggressively in AI to accelerate the creation of content, improve the safety of our platform, and fuel ongoing user engagement, discovery and monetization improvements.”

Jon Keegan
2h
Amazon slides as it misses on Q4 earnings, gives downbeat profit guidance

The tech giant also forecast it would spend $200 billion on capex in 2026.

New York Times DealBook Summit Held In New York City
Tasha Matsumoto
2h
Stocks erase 2026 gains as tech and crypto continue to slide; volatility rises

Investors continued to shun risk amid rising volatility.

GREEN BAY, WISCONSIN - DECEMBER 07: Caleb Williams #18 of the Chicago Bears walks off the field after a loss to the Green Bay Packers at Lambeau Field on December 07, 2025 in Green Bay, Wisconsin. (Photo by John Fisher/Getty Images)

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.
©2026 Sherwood Media, LLC